Seres Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Seres Therapeutics, Inc. (MCRB) reported Increase (Decrease) in Prepaid Expense and Other Assets of $2.19 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2021-03-02
- Seres Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2020-12-31 was -$868.00K.
- Seres Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2020-09-30 was $1.13M.
- Seres Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2020-06-30 was $2.13M.
- Seres Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2020-03-31 was -$203.00K, a 131.57% decline year-over-year.
- Seres Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $2.19M.
- Seres Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2019 was -$3.26M, a 258.41% decline from fiscal 2018.
- Seres Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2018 was $2.06M.
- Seres Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2017 was -$31.00K, a 101.19% decline from fiscal 2016.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$868.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $258.00K derived: sum of 2 quarters · filed 2021-03-02 | $2.39M derived: sum of 3 quarters · filed 2021-03-02 | $2.19M 10-K · filed 2021-03-02 |
| 2020-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.26M derived: sum of 2 quarters · filed 2020-11-09 | $3.05M 10-Q · filed 2020-11-09 | $2.57M derived: sum of 4 quarters · filed 2021-03-02 |
| 2020-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $1.93M 10-Q · filed 2020-07-28 | $1.44M derived: sum of 3 quarters · filed 2021-03-02 | $356.00K derived: sum of 4 quarters · filed 2021-03-02 |
| 2020-03-31 | -$203.00K 10-Q · filed 2020-05-07 | -$688.00K derived: sum of 2 quarters · filed 2021-03-02 | -$1.77M derived: sum of 3 quarters · filed 2021-03-02 | -$4.10M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-12-31 | -$485.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$1.57M derived: sum of 2 quarters · filed 2021-03-02 | -$3.90M derived: sum of 3 quarters · filed 2021-03-02 | -$3.26M 10-K · filed 2021-03-02 |
| 2019-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$3.42M derived: sum of 2 quarters · filed 2020-11-09 | -$2.77M 10-Q · filed 2020-11-09 | -$2.18M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-30 | -$2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | -$1.69M 10-Q · filed 2020-07-28 | -$1.09M derived: sum of 3 quarters · filed 2021-03-02 | -$5.00K derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-31 | $643.00K 10-Q · filed 2020-05-07 | $1.24M derived: sum of 2 quarters · filed 2021-03-02 | $2.32M derived: sum of 3 quarters · filed 2021-03-02 | $3.53M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-31 | $595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $1.68M derived: sum of 2 quarters · filed 2021-03-02 | $2.89M derived: sum of 3 quarters · filed 2021-03-02 | $2.06M 10-K · filed 2021-03-02 |
| 2018-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.30M derived: sum of 2 quarters · filed 2019-11-05 | $1.46M 10-Q · filed 2019-11-05 | $1.21M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $376.00K 10-Q · filed 2019-08-06 | $125.00K derived: sum of 3 quarters · filed 2020-03-02 | $632.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$835.00K 10-Q · filed 2019-05-02 | -$1.09M derived: sum of 2 quarters · filed 2020-03-02 | -$579.00K derived: sum of 3 quarters · filed 2020-03-02 | -$928.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $256.00K derived: sum of 2 quarters · filed 2020-03-02 | -$93.00K derived: sum of 3 quarters · filed 2020-03-02 | -$31.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $507.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $158.00K derived: sum of 2 quarters · filed 2018-11-08 | $220.00K 10-Q · filed 2018-11-08 | $291.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | -$349.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$287.00K 10-Q · filed 2018-08-02 | -$216.00K derived: sum of 3 quarters · filed 2019-03-06 | -$408.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | $62.00K 10-Q · filed 2018-05-09 | $133.00K derived: sum of 2 quarters · filed 2019-03-06 | -$59.00K derived: sum of 3 quarters · filed 2019-03-06 | $1.62M derived: sum of 4 quarters · filed 2019-03-06 |
| 2016-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$121.00K derived: sum of 2 quarters · filed 2019-03-06 | $1.56M derived: sum of 3 quarters · filed 2019-03-06 | $2.60M 10-K · filed 2019-03-06 |
| 2016-09-30 | -$192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.49M derived: sum of 2 quarters · filed 2017-11-08 | $2.53M 10-Q · filed 2017-11-08 | $2.04M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.72M 10-Q · filed 2017-08-03 | $2.23M derived: sum of 3 quarters · filed 2018-03-08 | $2.96M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $1.04M 10-Q · filed 2017-05-04 | $548.00K derived: sum of 2 quarters · filed 2018-03-08 | $1.28M derived: sum of 3 quarters · filed 2018-03-08 | $2.80M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | -$492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $240.00K derived: sum of 2 quarters · filed 2018-03-08 | $1.76M derived: sum of 3 quarters · filed 2018-03-08 | $2.47M 10-K · filed 2018-03-08 |
| 2015-09-30 | $732.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $2.25M derived: sum of 2 quarters · filed 2016-11-10 | $2.96M 10-Q · filed 2016-11-10 | $2.73M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $2.23M 10-Q · filed 2016-08-11 | $2.00M derived: sum of 3 quarters · filed 2017-03-16 | $2.24M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $710.00K 10-Q · filed 2016-05-16 | $479.00K derived: sum of 2 quarters · filed 2017-03-16 | $723.00K derived: sum of 3 quarters · filed 2017-03-16 | |
| 2014-12-31 | -$231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $13.00K derived: sum of 2 quarters · filed 2017-03-16 | $7.00K 10-K · filed 2017-03-16 | |
| 2014-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $238.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | -$6.00K 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | $21.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |